These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1353075)

  • 1. Misuse of antacid and H2 receptor antagonists in routine clinical practice.
    Wander GS; Gulati R; Bhatia RS
    J Assoc Physicians India; 1992 Mar; 40(3):207. PubMed ID: 1353075
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacids vs. antacids plus non-prescription ranitidine for heartburn during pregnancy.
    Rayburn W; Liles E; Christensen H; Robinson M
    Int J Gynaecol Obstet; 1999 Jul; 66(1):35-7. PubMed ID: 10458549
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of stress ulcers: antacid titration vs. histamine2-receptor blockade.
    Gonzalez ER; Morkunas AR
    Drug Intell Clin Pharm; 1985 Nov; 19(11):807-11. PubMed ID: 2866078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness and tolerance of selected Polish antacids in the therapy of duodenal ulcer disease. A placebo- and ranitidine-controlled study].
    Mach T
    Pol Tyg Lek; 1995; 50(1-35):797-800. PubMed ID: 11785199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Leditschke IA; Coombes JA
    Med J Aust; 2000 Jun; 172(11):564. PubMed ID: 10920757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antacids, histamine H2 receptor antagonists].
    Raphaël M
    Soins; 1988 Apr; (511):I-II. PubMed ID: 2899911
    [No Abstract]   [Full Text] [Related]  

  • 13. Antacids and H2-receptor antagonists in the prophylaxis and treatment of erosive gastritis: clinical aspects.
    Ivarsson LE
    Scand J Gastroenterol Suppl; 1984; 105():86-91. PubMed ID: 6152358
    [No Abstract]   [Full Text] [Related]  

  • 14. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

  • 15. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of uncomplicated duodenal ulcer with an antacid-containing attapulgite. Effectiveness and tolerance in comparison with a H2 receptor antagonist].
    Mayer R; Sack W; Wagner W
    Fortschr Med; 1985 Dec; 103(45):1055-8. PubMed ID: 2867015
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M; Bianchi Porro G
    Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
    Ivashkin VT; Minasian GA
    Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
    [No Abstract]   [Full Text] [Related]  

  • 19. Stress-related gastritis: focus on the use of H2-receptor antagonists and antacids.
    Chime-Udeh E
    Conn Med; 1993 Jan; 57(1):29-32. PubMed ID: 8095445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ranitidine (Zantac). A new H2 receptor antagonist].
    Bendtsen F; Danø P
    Ugeskr Laeger; 1983 Nov; 145(47):3681-2. PubMed ID: 6140786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.